News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Elisa Agostinetto: Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence
Mar 15, 2024, 15:38

Elisa Agostinetto: Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence

Elisa Agostinetto, Clinical Research Fellow at Jules Bordet Institute in Brussels, shared a post on X:

“Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence, ctDNA detection had very high specificity for anticipating relapse.”

View the article.
Source: Elisa Agostinetto/X

Breast Cancer cancer ctDNA early stage disease Elisa Agostinetto Guilherme Nader Marta meta-analysis OncoDaily Oncology recurrence
Special Coverage
Blog
Mar 30, 2025, 03:45
Miriam Mutebi: We are looking for ways to expand surgical capacity in Africa
Blog
Mar 30, 2025, 03:34
Optimizing Interdisciaplinary Psychosocial Support and more - National Comprehensive Cancer Network
Blog
Mar 30, 2025, 03:26
Celebrating 1,000 Followers on LinkedIn - The Babak Lab
Blog
Mar 30, 2025, 03:18
Gregg Margolis: A very big week in health policy
Blog
Mar 30, 2025, 00:07
Abbigail and Team LUNGevity continue their final weeks of training for the Big Sur Marathon: LUNGevity Foundation
Career
Mar 29, 2025, 23:56
Arun Srivastava has been named a 2024 fellow of the AAAS: UF Health Cancer Center
Insight
Mar 29, 2025, 23:37
Sitna Ali Mwanzi: Molecular Profile of NSCLC in a predominantly Black African Population in Kenya
Blog
Mar 29, 2025, 23:14
Join us live for the Open Plenary Session: Common Sense Oncology
Insight
Mar 29, 2025, 23:04
Naveen Pemmaraju: Polycythemia vera: past, present and future
Insight
Mar 29, 2025, 21:34
Elvina Almuradova: Pembrolizumab plus CRT as the New Standard in Locally Advanced Cervical Cancer
Blog
Mar 29, 2025, 21:16
Shivani Modi: Honored to present 3 posters at ASCO and 5 published abstracts
Blog
Mar 29, 2025, 20:53
We’re Back for the Jimmy Fund Walk 2025: Florez Lab